Annual report pursuant to Section 13 and 15(d)

Restricted Cash Equivalents and Investments (Schedule of Estimated Fair Value of Available-for-Sale Securities) (Details)

v3.23.1
Restricted Cash Equivalents and Investments (Schedule of Estimated Fair Value of Available-for-Sale Securities) (Details)
Dec. 31, 2022
USD ($)
Schedule of Available-for-sale Securities [Line Items]  
Amortized Cost $ 3,694,069
Estimated Market Value 3,645,228
Investments [Member]  
Schedule of Available-for-sale Securities [Line Items]  
Amortized Cost, Due within one year 2,715,607
Amortized Cost 2,715,607
Estimated Market Value, Due within one year 2,666,766
Estimated Market Value $ 2,666,766